全文获取类型
收费全文 | 142260篇 |
免费 | 12026篇 |
国内免费 | 6959篇 |
专业分类
耳鼻咽喉 | 1403篇 |
儿科学 | 2121篇 |
妇产科学 | 3349篇 |
基础医学 | 17491篇 |
口腔科学 | 2711篇 |
临床医学 | 16815篇 |
内科学 | 24042篇 |
皮肤病学 | 2012篇 |
神经病学 | 8160篇 |
特种医学 | 5368篇 |
外国民族医学 | 38篇 |
外科学 | 16089篇 |
综合类 | 17048篇 |
现状与发展 | 21篇 |
一般理论 | 23篇 |
预防医学 | 8900篇 |
眼科学 | 3486篇 |
药学 | 13769篇 |
100篇 | |
中国医学 | 5952篇 |
肿瘤学 | 12347篇 |
出版年
2024年 | 416篇 |
2023年 | 1790篇 |
2022年 | 4445篇 |
2021年 | 6110篇 |
2020年 | 4329篇 |
2019年 | 4154篇 |
2018年 | 4711篇 |
2017年 | 3963篇 |
2016年 | 3876篇 |
2015年 | 5831篇 |
2014年 | 7182篇 |
2013年 | 7355篇 |
2012年 | 10790篇 |
2011年 | 11020篇 |
2010年 | 7054篇 |
2009年 | 5810篇 |
2008年 | 7882篇 |
2007年 | 7678篇 |
2006年 | 7151篇 |
2005年 | 6836篇 |
2004年 | 5500篇 |
2003年 | 5124篇 |
2002年 | 4525篇 |
2001年 | 3590篇 |
2000年 | 3467篇 |
1999年 | 3277篇 |
1998年 | 1810篇 |
1997年 | 1697篇 |
1996年 | 1384篇 |
1995年 | 1320篇 |
1994年 | 1113篇 |
1993年 | 720篇 |
1992年 | 1260篇 |
1991年 | 1086篇 |
1990年 | 956篇 |
1989年 | 864篇 |
1988年 | 718篇 |
1987年 | 726篇 |
1986年 | 587篇 |
1985年 | 478篇 |
1984年 | 350篇 |
1983年 | 272篇 |
1982年 | 176篇 |
1981年 | 167篇 |
1980年 | 132篇 |
1979年 | 249篇 |
1978年 | 177篇 |
1977年 | 117篇 |
1976年 | 123篇 |
1974年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
本研究选择10μg/ml、20μg/ml、40μg/ml浓度的溴氰菊酯处理白纹伊蚊C6/36细胞,以MMC作为阳性对照物,观察溴氰菊酯处理24h后对C6/36细胞染色体畸变率和姐妹染色单体互换(SCE)频率的影响。结果显示,三个浓度的溴氰菊酯对C6/36细胞染色体畸变率均没有显著影响(P<0.05);溴氰菊酯浓度在40μg/ml时可诱导C6/36细胞SCE频率轻度增高(P>0.05),而溴氰菊酯浓度在10μg/ml、20μg/ml时,对C6/36细胞SCE频率没有诱导作用。表明溴氰菊酯对C6/36细胞的遗传学效应较弱 相似文献
62.
63.
Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease 总被引:1,自引:0,他引:1
K Steingold D De Ziegler M Cedars D R Meldrum J K Lu H L Judd R J Chang 《The Journal of clinical endocrinology and metabolism》1987,65(4):773-778
Previously, we reported that short term administration of a highly potent GnRH agonist (GnRHa) for 1 month to patients with polycystic ovarian disease (PCO) resulted in complete suppression of ovarian steroidogenesis without measurable effects on adrenal steroid production. This new study was designed to evaluate the effects of long term GnRHa administration in PCO patients with respect to their hormone secretion patterns and clinical responses. Eight PCO patients and 10 ovulatory women with endometriosis were treated daily with sc injections of [D-His6-(imBzl]),Pro9-NEt]GnRH (GnRHa; 100 micrograms) for 6 months. Their results were compared to hormone values in 8 women who had undergone bilateral oophorectomies. In response to GnRHa, PCO and ovulatory women had rises of serum LH at 1 month, after which it gradually declined to baseline. In both groups FSH secretion was suppressed throughout treatment. Serum estradiol, estrone, progesterone, 17-hydroxyprogesterone, androstenedione, and testosterone levels markedly decreased to values found in oophorectomized women by 1 month and remained low thereafter. In contrast, serum pregnenolone and 17-hydroxypregnenolone were partially suppressed, and dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol levels did not change. Clinically, hyperplastic endometrial histology in three PCO patients reverted to an inactive pattern, and proliferative endometrium in two other PCO patients became inactive in one and did not change in the other. Regression of proliferative endometrial histology occurred in all ovulatory women. Vaginal bleeding occurred in all women studied during the first month of GnRHa administration, after which all but one PCO patient became amenorrheic. Hot flashes were noted by all ovulatory women and by four of eight PCO patients. All PCO patients noted subjective reduction of skin oiliness, and five had decreased hair growth. We conclude that in premenopausal women: 1) chronic GnRHa administration results in apparently complete persistent suppression of ovarian steroid secretion; 2) adrenal steroid secretion is not influenced directly or indirectly; and 3) its use may be helpful in the treatment of endometrial hyperplasia and ovarian androgen excess in women with PCO. 相似文献
64.
复方华蟾胶囊抗小鼠肿中瘤作用的实验研究 总被引:2,自引:0,他引:2
目的了解复方华蟾胶囊抗小鼠移植性肿瘤的作用.方法以小鼠肝癌22(H22)、小鼠肉瘤180(S180)为瘤株,应用动物移植性肿瘤的体内试验法对药物进行抗癌药效学试验.结果复方华蟾胶囊灌胃4,2 g/kg@d,连续14 d,对小鼠移植性肝癌实体型生长有明显的抑制作用,抑瘤率分别为38.09%,30.95%.对小鼠移植性S180实体型生长有明显的抑制作用,抑瘤率分别为34.7%,30.08%.复方华蟾胶囊对荷瘤小鼠的胸腺和脾脏重量无影响.结论复方华蟾胶囊在试验条件下有一定抗肿瘤作用. 相似文献
65.
66.
本文报告用亚致死剂量的 S—31183(类保幼激素)处理三带喙库蚊幼虫对其发育影响的研究,结果表明处理后蛹期死亡率明显高于幼虫期,并且与剂量大小有关。S—31183处理幼虫并不影响幼虫的发育时间,但可使幼虫化蛹时蜕皮受阻与羽化受到一定的抑制。 相似文献
67.
68.
目的;探讨临床医师对X综合征的临床诊断水平并了解其发病机制;方法:对186例有胸痛的女性患者(平均年龄53.2岁)通过运动试验,左室功能及冠状动脉造影来评估X综合征患者冠脉微循环功能及发病机制;结果:186例中86人(46%)冠脉造影阴性,运动试验阳性,左室功能无明显失调;结论:X综合征多见于女性,X综合征可能是由于冠脉微血管功能异常所致。 相似文献
69.
胃癌组织端粒酶活性与催化亚基hTERT表达的关系 总被引:1,自引:0,他引:1
研究胃癌、胃黏膜肠化生及正常黏膜组织端粒酶活性与人端粒酶催化亚基(hTERT)表达的相关性及端粒酶激活在胃癌发生中的作用.方法:通过端粒重复序列扩增(TRAP)和逆转录聚合酶链反应(RT -PCR)方法测定3种胃癌细胞株、26例胃癌、10例胃黏膜肠化生和36例正常胃黏膜组织标本端粒酶活性和hTERT表达.结果:3种胃癌细胞株、24例胃癌组织有端粒酶活性;4例肠化生端粒酶活性较弱;36例正常胃黏膜标本未测到端粒酶活性.hTERT在26例胃癌组织、5例肠化胃黏膜中表达;正常胃黏膜无表达.端粒酶活性、hTERT表达与肿瘤的分期和病理分级无关.结论:hTERT在肿瘤形成的早期阶段表达,端粒酶的激活是胃癌形成的关键步骤. 相似文献
70.
No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. 总被引:6,自引:0,他引:6
B Riecken R Pfeiffer J L Ma M L Jin J Y Li W D Liu L Zhang Y S Chang M H Gail W C You 《Preventive medicine》2002,34(1):22-28
BACKGROUND: Gastric cancer (GC) is the leading cause of cancer deaths in China. Our study prospectively evaluated the impact of repeated endoscopic screens on GC mortality in a high-risk population in China. METHODS: Between 1989 and 1999, a population-based gastroscopic screening was conducted in 4,394 residents of Linqu County, China, a region with the highest rates of GC worldwide. Residents ages 35 to 64 years received initial gastroscopies with biopsies in 1989. Repeated endoscopies were performed in 1994 and 1999. Cancer occurrences and deaths were actively monitored throughout the entire period until July 2000. Mortality from GC was compared with expected values based on mortality rates obtained for Linqu in the 1990-1992 Chinese Cancer Mortality Survey. RESULTS: Between March 1989 and July 2000, 39,303 person-years were accumulated; 85 new GCs occurred, 29 (34.5%) were in early stage. Fifty-eight cases (68%) were identified at one of the screens. The number of observed deaths from GC (37) was close to the expected (36.8). The standardized mortality ratio was 1.01 (95% CI 0.72-1.37) for the entire cohort, 1.13 (95% CI 0.77-1.57) for males, and 0.65 (95% CI 0.26-1.32) for females. CONCLUSIONS: Despite high population coverage with repeated screens, no reduction in GC mortality was observed in this high-risk population in China. 相似文献